Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 14, Issue 9, Pages 1151-1160
Publisher
Informa Healthcare
Online
2013-04-27
DOI
10.1517/14656566.2013.794223
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS
- (2012) F. Cremonini et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
- (2012) Rebecca M. Lovell et al. Clinical Gastroenterology and Hepatology
- Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea
- (2012) Banny S. Wong et al. Clinical Gastroenterology and Hepatology
- Pharmacogenetics of the Effects of Colesevelam on Colonic Transit in Irritable Bowel Syndrome with Diarrhea
- (2012) Banny S. Wong et al. DIGESTIVE DISEASES AND SCIENCES
- Activation of Colonic Mucosal 5-HT4 Receptors Accelerates Propulsive Motility and Inhibits Visceral Hypersensitivity
- (2012) Jill M. Hoffman et al. GASTROENTEROLOGY
- Peripheral Mechanisms in Irritable Bowel Syndrome
- (2012) Michael Camilleri NEW ENGLAND JOURNAL OF MEDICINE
- Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome – a pilot study
- (2012) Ashok K. Tuteja et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study
- (2011) J. F. Tack et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome
- (2011) C. N. Andrews et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
- (2011) Stacy B Menees et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome
- (2011) M Camilleri CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Tryptophan Hydroxylase Inhibitor LX1031 Shows Clinical Benefit in Patients With Nonconstipating Irritable Bowel Syndrome
- (2011) Philip M. Brown et al. GASTROENTEROLOGY
- Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine
- (2011) K. J. Lee et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
- (2011) Mark Pimentel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome
- (2010) H. VAHEDI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ischemic Colitis and Complications of Constipation Associated With the Use of Alosetron Under a Risk Management Plan: Clinical Characteristics, Outcomes and Incidences
- (2010) Lin Chang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Evolution of Clinical Trials for Irritable Bowel Syndrome: Issues in End Points and Study Design
- (2010) Ann Marie Trentacosti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression
- (2010) Megan Friedrich et al. CLINICAL THERAPEUTICS
- Serotonin Signaling Is Altered in Irritable Bowel Syndrome With Diarrhea but Not in Functional Dyspepsia in Pediatric Age Patients
- (2010) Christophe Faure et al. GASTROENTEROLOGY
- The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
- (2010) T. K. Klooker et al. GUT
- Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
- (2010) Lena Öhman et al. Nature Reviews Gastroenterology & Hepatology
- Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study
- (2009) R. CORINALDESI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome
- (2009) L. WEDLAKE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function
- (2009) Suwebatu T. Odunsi–Shiyanbade et al. Clinical Gastroenterology and Hepatology
- Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome
- (2008) A. W. MANGEL et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Predictors of Patient-Assessed Illness Severity in Irritable Bowel Syndrome
- (2008) Brennan Spiegel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2008) Viola Andresen et al. Clinical Gastroenterology and Hepatology
- Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome
- (2008) M CAMILLERI et al. Clinical Gastroenterology and Hepatology
- A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome
- (2008) K. Matsueda et al. DIGESTION
- The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
- (2008) P. Moayyedi et al. GUT
- Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
- (2008) A C Ford et al. GUT
- Effects of serotonin 5-HT3receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer
- (2008) t. hirata et al. NEUROGASTROENTEROLOGY AND MOTILITY
- A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome
- (2008) Kei Matsueda et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More